Background Image
Table of Contents Table of Contents
Previous Page  290 / 337 Next Page
Information
Show Menu
Previous Page 290 / 337 Next Page
Page Background

SCIENTIFIC PROGRAMME

290

WEDNESDAY

THURSDAY

FRIDAY

SATURDAY

› Saturday, 28 Nov 2015

S-168

Symposium

08.30– 10.00 h

|

Hall New York 1

TOPIC 3:

Psychotic disorders, F2

Schizophrenia (imaging) genetics: from

bench to bedside – the next steps

Chairs:

Henrik Walter, Berlin (Germany)

Franziska Degenhardt, Bonn (Germany)

001

Psychiatric Genomics Consortium:

an update on GWAS in schizophrenia

Stephan Ripke, Berlin (Germany)

002

Imaging genetics of the major psy-

choses: what have we learned and what

can we achieve?

Henrik Walter, Berlin (Germany)

003

Imaging effects of schizophrenia

risk genes in patients and controls: a

critical update

Igor Nenadic, Jena (Germany)

004

Schizophrenia Genetics – First steps

towards clinical translation and genetic

counseling

Franziska Degenhardt, Bonn (Germany)

PR-04

President's Symposium

10.15– 11.45 h

|

Hall A6

TOPIC 32:

Others topics

Self-awareness, Default Mode Network

and mental disorders

Chairs:

Iris Hauth, Berlin (Germany)

Andreas Meyer-Lindenberg, Mannheim

(Germany)

001

Self-awareness and schizophrenia

Josef Parnas, Copenhagen (Denmark)

002

Memory, autonoetic consciousness,

and the self

Hans J. Markowitsch, Bielefeld (Germany)

003

Self-awareness and autism

Kai Vogeley, Cologne (Germany)

004

Default Mode, mental processes and

disorders

Simon Eickhoff, Dusseldorf (Germany)

HS-29

Main Symposium

10.15– 11.45 h

|

Hall London 2

TOPIC 13:

Brain imaging, neurophysiology,

neuropsychology

New avenues for the treatment of

mental disorders by oxytocin: accelera-

tion of fear extinction and promotion of

sociality

Section: Neurobiology and Genetics

Chairs:

René Hurlemann, Bonn (Germany)

Valery Grinevich, Heidelberg (Germany)

001

Oxytocin facilitates the acquisition

and extinction of fear in humans

René Hurlemann, Bonn (Germany)

002

Central oxytocin pathways of fear

and sociality

Valery Grinevich, Heidelberg (Germany)

003

The role of oxytocin in the regula-

tion of social bonding

Dirk Scheele, Bonn (Germany)

004

Is oxytocin a useful therapeutic

agent in borderline personality disorder?

Martin Brüne, Bochum (Germany)

S-183

Symposium

10.15– 11.45 h

|

Room M4

TOPIC 14:

Neurobiology and genetics

Innovative strategies to identify and

characterize risk genes for psychiatric

disorders

Chairs:

Thomas Nickl-Jockschat, Aachen

(Germany)

Ted Abel, Philadelphia (USA)

001

Copy number variation models of

psychiatric disorders

Ted Abel, Philadelphia (USA)

002

New strategies for animal imaging

in the characterization of psychiatric

disorders

Thomas Nickl-Jockschat, Aachen (Germany)

003

Genetic and epigenetic moderators

of glucocorticoid-induced gene expres-

sion and DNA methylation changes

– candidate loci for stress-related psychi-

atric disorder

Elisabeth Binder, Munich (Germany)